Dr. Salmon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 E W T Harris Blvd
Ste 5500
Charlotte, NC 28262Phone+1 704-863-6160Fax+1 704-863-6161
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Virginia Medical CenterResidency, Internal Medicine, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2005 - 2025
TN State Medical License 2003 - 2006
VA State Medical License 1999 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 12 citationsA Complete Pathological Response to Pembrolizumab following ex vivo Liver Resection in a Patient with Colorectal Liver Metastases.Maria Baimas-George, Erin H. Baker, Michal Kamionek, J. Stuart Salmon, A. Sastry
Chemotherapy. 2018-04-05 - 38 citationsNon-Hodgkin's Lymphoma Involving the Liver: Clinical and Therapeutic ConsiderationJ. Stuart Salmon, Mary Ann Thompson, Ronald C. Arildsen, John P. Greer
Clinical Lymphoma & Myeloma. 2006-01-01 - 356 citationsAberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancerJoseph M. Amann, Shailaja Kalyankrishna, Pierre P. Massion, Joyce E. Ohm, Luc Girard
Cancer Research. 2005-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
